Analyst Price Forecast Suggests 185.10% Upside As of December 3, 2024, the average one-yearprice targetfor Aquestive Therapeutics is $10.26/share. The forecasts range from a low of $5.56 to a high of $15.75. The average price target represents an increase of 185.10% from it...